OBJECTIVES: To describe case mix variation among institutions, and report adverse event rates in congenital cardiac catheterization by case type. BACKGROUND: Reported adverse event rates for patients with congenital heart disease undergoing cardiac catheterization vary considerably, due to non-comparable standards of data inclusion, and highly variable case mix. METHODS: The Congenital Cardiac Catheterization Outcomes Project (C3PO) has been capturing case characteristics and adverse events (AE) for all cardiac catheterizations performed at six pediatric institutions. Validity and completeness of data were independently audited. RESULTS: Between 2/1/07 and 4/30/08, 3855 cases (670 biopsy, 1037 diagnostic, and 2148 interventional) were recorded, median number of cases per site 480 (308 to 1526). General anesthesia was used in 70% of cases (28 to 99%), and 22% of cases (15 to 26%) were non-electively or emergently performed. Three institutions performed a higher proportion of interventions during a case, 72 to 77% compared to 56 to 58%. The median rate of AE reported per institution was 16%, ranging from 5 to 18%. For interventional cases the median rate of AE reported per institution was 19% (7 to 25%) compared to 10% for diagnostic cases (6 to 16%). The incidence of AE was significantly higher for interventional compared to diagnostic cases (20% vs 10%, p<0.001), as was the incidence of higher severity AE (9% vs 5%, p<0.001). Adverse events in biopsy cases were uncommon. CONCLUSIONS: In this multi-institutional cohort, the incidence of AE is higher among interventional compared to diagnostic cases, and is very low among biopsy cases. Equitable comparisons among institutions will require the development and application of risk adjustment methods.
OBJECTIVES: To describe case mix variation among institutions, and report adverse event rates in congenital cardiac catheterization by case type. BACKGROUND: Reported adverse event rates for patients with congenital heart disease undergoing cardiac catheterization vary considerably, due to non-comparable standards of data inclusion, and highly variable case mix. METHODS: The Congenital Cardiac Catheterization Outcomes Project (C3PO) has been capturing case characteristics and adverse events (AE) for all cardiac catheterizations performed at six pediatric institutions. Validity and completeness of data were independently audited. RESULTS: Between 2/1/07 and 4/30/08, 3855 cases (670 biopsy, 1037 diagnostic, and 2148 interventional) were recorded, median number of cases per site 480 (308 to 1526). General anesthesia was used in 70% of cases (28 to 99%), and 22% of cases (15 to 26%) were non-electively or emergently performed. Three institutions performed a higher proportion of interventions during a case, 72 to 77% compared to 56 to 58%. The median rate of AE reported per institution was 16%, ranging from 5 to 18%. For interventional cases the median rate of AE reported per institution was 19% (7 to 25%) compared to 10% for diagnostic cases (6 to 16%). The incidence of AE was significantly higher for interventional compared to diagnostic cases (20% vs 10%, p<0.001), as was the incidence of higher severity AE (9% vs 5%, p<0.001). Adverse events in biopsy cases were uncommon. CONCLUSIONS: In this multi-institutional cohort, the incidence of AE is higher among interventional compared to diagnostic cases, and is very low among biopsy cases. Equitable comparisons among institutions will require the development and application of risk adjustment methods.
Authors: Francesco De Sanctis; Matteo Di Nardo; Alessandro Inserra; Zaccaria Ricci; Maria Antonietta Barbieri; Marco Marano; Sergio Picardo Journal: Int J Cardiovasc Imaging Date: 2011-10-19 Impact factor: 2.357
Authors: Christopher G Watson; Christian Stopp; David Wypij; Jane W Newburger; Michael J Rivkin Journal: Pediatr Res Date: 2017-02-03 Impact factor: 3.756
Authors: Kimberly I Mills; Julie A Vincent; Warren A Zuckerman; Timothy M Hoffman; Charles E Canter; Audrey C Marshall; Elizabeth D Blume; Lisa Bergersen; Kevin P Daly Journal: Pediatr Cardiol Date: 2016-06-06 Impact factor: 1.655
Authors: Natalie Jayaram; Robert H Beekman; Lee Benson; Ralf Holzer; Kathy Jenkins; Kevin F Kennedy; Gerard R Martin; John W Moore; Richard Ringel; Jonathan Rome; John A Spertus; Robert Vincent; Lisa Bergersen Journal: Circulation Date: 2015-10-19 Impact factor: 29.690
Authors: Priscila C Cevallos; Molly J Rose; Laurie B Armsby; Aimee K Armstrong; Howaida El-Said; Susan R Foerster; Andrew C Glatz; Bryan H Goldstein; Michael R Hainstock; Jacqueline Kreutzer; Larry A Latson; Ryan A Leahy; Christopher J Petit; Alejandro Torres; Shabana Shahanavaz; Jeffrey D Zampi; Lisa Bergersen Journal: Pediatr Cardiol Date: 2016-08-08 Impact factor: 1.655
Authors: Andrew C Glatz; Akash Patel; Xiaowei Zhu; Yoav Dori; Brian D Hanna; Matthew J Gillespie; Jonathan J Rome Journal: Pediatr Cardiol Date: 2014-01-18 Impact factor: 1.655
Authors: Carrie E Herbert; Jenny Leshko; Dawn Morelli; Ernest Amankwah; Jade Hanson; Gary E Stapleton Journal: Pediatr Cardiol Date: 2019-08-02 Impact factor: 1.655